High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in breast cancer

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 40, Issue , 1997, Pages

  Tokuda, Yutaka ^a   Ohta, Masatoshi ^a   Okumura, Akira ^a   Kuge, Soichi ^a   Kubota, Mitsuhiro ^a   Tajima, Tomoo ^a   Mitomi, Toshio ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Autologous hematopoietic stem cell transplantation; Breast cancer; High dose chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; NIMUSTINE; THIOTEPA;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; AXILLARY LYMPH NODE; BONE MARROW SUPPRESSION; BREAST CANCER; CLINICAL TRIAL; CONFERENCE PAPER; DEATH; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; RISK FACTOR; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; SURVIVAL RATE;

EID: 0030738406     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051069     Document Type: Conference Paper

References (9)

1. Antman K, Corringham R, Vries E de, Elfenbein G, Gianni AM, Gisselbrecht C, Herzig R, Juttner C, Kaizer H, Kennedy MJ, Kessinger A, Kotasek D, Lazarus H, Ljungman P, Maraninchi D, Nabholtz J, Niederwieser D, Ogawa M, Patrone F, Peters W, Rosti G, Rouesse J, Schilcher R, Selby G, Shea T, Shpall E, Spitzer G, Sweet D, Tajima T, Vaughan W, Williams S, Wolff S (1992) Dose intensive therapy in breast cancer. Bone Marrow Transplant 10 [Suppl 1]:67
2. Budman DR, Wood W, Henderson IC, Korzun AH, Cooper R, Younger J, Hart RD, Moore A, Ellerton J, Norton L, Ferree C, Colangelo A, McIntyre OR (1992) Initial findings of CALGB 8541: a dose and dose intensity trial of cyclophosphamide (C), doxorubicin (A), and 5-fluorouracil (F) as adjuvant treatment of stage II, node+, female breast cancer. Proc Am Soc Clin Oncol 11:51
3. Eder JP, Elias A, Shea TC, Schryber SM, Teicher BA, Hunt M, Burke J, Siegel R, Schnipper LE, Frei E III, Antman K (1990) A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients. J Clin Oncol 8:1239
4. Frei E III, Canellos GP (1980) Dose: a critical factor in cancer chemotherapy. Am J Med 69:585
5. Peters WP, Ross M, Vredenburgh JJ, Meisenberg B, Marks LB, Winer E, Kurtzberg J, Bast RC, Jones R Jr, Shpall E, Wu K, Rosner G, Gilbert C, Mathias B, Coniglio D, Petros W, Henderson IC, Norton L, Weiss RB, Budman D, Hurd D (1993) High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11:1132
6. Spitzer G, Adkins D, Dunphy F, Petruska P, Spencer V, Velasquez W (1993) Design of preparative regimens for stem-cell transplantation in breast cancer. Breast Cancer Res Treat 26 [Suppl 1]:S3
7. Tannock IF, Boyd NF, DeBoer G, Erlichman C, Larocque G, Mayers C, Perrault D, Sutherland H (1988) A randomized trial of two dose levels of CMF chemotherapy for patients with metastatic breast cancer. J Clin Oncol 6:1377
8. Tobinai K, Kohno A, Shimada Y, Watanabe T, Tamura T, Takeyama K, Narabayashi M, Fukutomi T, Kondo H, Shimoyama M, Suemasu K, Members of the Clinical Trial Review Committee of the Japan Clinical Oncology Group (1993) Toxicity grading criteria of the Japan Clinical Oncology Group. Jpn J Clin Oncol 23:250
9. Tokuda Y, Tajima T, Norihisa Y, Ohta M, Fujimoto T, Tanaka Y, Kubota M, Yokoyama S, Mitomi T, Murakami M, Shinozuka T, Ogawa J, Inoue H, Nakamura Y, Watanabe K, Habu S, Tsuji K (1989) Hematopoietic recovery after autologous bone marrow transplantation in high-dose chemotherapy for cancer patients. J Jpn Soc Cancer Ther 24:57